BRCA2 and breast carcinoma: Indications for RRM include: strong family history of breast and/or ovarian cancer; presence of mutations in high penetrance genes predisposing to breast cancer (such as BRCA1, BRCA2, TP53, PTEN and PALB2), and atypical proliferative abnormalities on breast histology [6].